Published in Obesity and Diabetes Week, October 4th, 2004
"New information regarding gastrointestinal mechanisms that participate in the control of food intake has extended our understanding of appetite control. Although each new signaling pathway discovered in the gut is a potential. target for drug development in the treatment of obesity, the growing number of such signaling molecules indicates that a highly complex process controls food intake," scientists in Switzerland report.
"The present summary focuses on the role of glucagon-like peptide 1 (GLP-1) in this regulatory process," said Jean-Pierre...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.